 | Up a level |
Lambert, M; Schöttle, D; Sengutta, M; Ruppelt, F; Rohenkohl, A; Luedecke, D; Nawara, LA; Galling, B; Falk, AL; Wittmann, L; Niehaus, V; Sarikaya, G; Handwerk, U; Rothländer, W; Rietschel, L; Gagern, C; Lange, B; Meigel-Schleiff, C; Naber, D; Schulte-Markwort, M; ... (2018). Early detection and integrated care for adolescents and young adults with severe psychotic disorders: rationales and design of the Integrated Care in Early Psychosis Study (ACCESS III). Early intervention in psychiatry, 12(1), pp. 96-106. Blackwell Publishing Asia 10.1111/eip.12361
Galling, B; Roldán, A; Hagi, K; Rietschel, L; Walyzada, F; Zheng, W; Cao, XL; Xiang, YT; Zink, M; Kane, JM; Nielsen, J; Leucht, S; Correll, CU (2017). Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis. World psychiatry, 16(1), pp. 77-89. Wiley 10.1002/wps.20387
Galling, B; Roldán, A; Rietschel, L; Hagi, K; Walyzada, F; Zheng, W; Cao, XL; Xiang, YT; Kane, JM; Correll, CU (2016). Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials. Expert Opinion on Drug Safety, 15(5), pp. 591-612. Taylor & Francis 10.1517/14740338.2016.1165668
